Simvastatin

component of oligomeric golgi complex 2 ; Homo sapiens







88 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 18226326 The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study. 2008 Mar 1
52 18332269 Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. 2008 Mar 25 2
53 18578957 LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results. 2008 Aug 1
54 18683797 [The effects of simvastatin withdrawal on brachial artery endothelial function in healthy normocholesterolemic men]. 2008 Feb 1
55 19014834 Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study. 2008 Oct 2
56 21291710 Efficacy of simvastatin therapy in attainment of LDL-C and TG goal levels in patients with type 2 diabetic dyslipidemia. 2008 Feb 2
57 21291712 Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes. 2008 Feb 1
58 17577472 A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targets. 2007 Mar 4
59 17711713 [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors]. 2007 Jun 2
60 16574035 Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. 2006 Mar 1
61 16799230 Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin. 2006 Jul 2
62 16893434 Efficacy, safety and LDL-C goal attainment of ezetimibe 10 mg-simvastatin 20 mg vs. placebo-simvastatin 20 mg in UK-based adults with coronary heart disease and hypercholesterolaemia. 2006 Aug 5
63 17084257 Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. 2006 Nov 7 4
64 17112329 Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. 2006 Nov 1
65 17319467 Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination. 2006 1
66 15864235 Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study. 2005 Mar 5
67 16369229 LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD. 2005 Jul 14 2
68 15132403 Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial. 2004 May 3
69 15324535 Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia. 2004 Aug 1
70 15334157 Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia. 2004 Jun 2
71 12637115 A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study. 2003 Jan 1
72 12774855 Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia. 2003 May 1
73 12029990 [Results of clinical epidemiology and intervention trial of hyperlipidemia in Japan]. 2002 May 1
74 12353340 Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study. 2002 Jul 2
75 12499611 Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. 2002 Dec 2
76 11318080 A comparison of the efficacy and tolerability of titrate-to-goal regimens of simvastatin and fluvastatin: a randomized, double-blind study in adult patients at moderate to high risk for cardiovascular disease. 2001 Mar 3
77 11383320 Treatment of heterozygous familial hypercholesterolemia: atorvastatin vs simvastatin. 2001 Feb 1
78 11440286 STATT: a titrate-to-goal study of simvastatin in Asian patients with coronary heart disease. Simvastatin Treats Asians to Target. 2001 Jun 1
79 11748098 Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. 2001 Dec 18 1
80 10740137 Statins: effective antiatherosclerotic therapy. 2000 Apr 1
81 9920147 Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on sterol absorption in hypercholesterolemic subjects. 1999 Jan 1
82 9793596 Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias. 1998 Oct 1
83 10095800 Effects of atorvastatin on serum lipids of patients with familial hypercholesterolaemia. 1998 Aug 1
84 10101552 Drug treatment of hypercholesterolaemia. 1998 Nov 1
85 18370543 Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study. 1998 2
86 9377621 Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials. 1997 Jul-Aug 1
87 7752830 Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. 1994 1
88 2634479 [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk]. 1989 Dec 1